The Searle Company Overview

  • Year Founded
  • 1965

Year Founded

  • Status
  • Public

  • Employees
  • 3,285

Employees

  • Stock Symbol
  • SEARL

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.28
  • (As of Thursday Closing)

The Searle Company General Information

Description

The Searle Co Ltd is engaged in the manufacturing and sale of pharmaceutical and consumer healthcare products. Its portfolio includes prescription medicines, biopharmaceuticals, nutraceuticals, nutritional products, medical devices, and disposables. Key products include Semavi, Rexeva, Valmera, Injecfer, Dalimab, and Extor. The group serves therapeutic areas including cardiovascular, endocrinology, oncology, neurology, respiratory care, gastroenterology, hepatology, and anti-infectives. The majority of the group's revenue is generated from pharmaceutical sales. Geographically, the group generates the majority of its revenue from Pakistan, with additional sales from Sri Lanka, Myanmar, Cambodia, Afghanistan, Vietnam, Oman, and other countries.

Contact Information

Formerly Known As
G.D. Searle (Pakistan)
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • One IBL Centre, 2nd Floor, Plot # 1, Block 7 & 8, D.M.C.H.S
  • Tipu Sultan Road. Off Shahra-e-Faisal
  • Karachi, 74400
  • Pakistan
+92 (071)
Primary Industry
Pharmaceuticals
Stock Exchange
KAR
Corporate Office
  • One IBL Centre, 2nd Floor, Plot # 1, Block 7 & 8, D.M.C.H.S
  • Tipu Sultan Road. Off Shahra-e-Faisal
  • Karachi, 74400
  • Pakistan
+92 (071)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The Searle Company Stock Performance

As of 12-Nov-2026, The Searle Company’s stock price is $0.28. Its current market cap is $163M with 588M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.28 $0.28 $0.26 - $0.49 $163M 588M 1.65M

The Searle Company Financials Summary

As of 30-Sep-2026, The Searle Company has a trailing 12-month revenue of $136M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 192,735 228,096 186,677 167,241
Revenue 136,112 130,343 101,867 103,638
EBITDA 23,245 20,856 15,751 20,588
Net Income 2,429 1,559 (4,981) (8,376)
Total Assets 182,465 184,446 171,822 227,164
Total Debt 31,498 28,809 27,999 47,335
Public Fundamental Data provided by Morningstar, Inc. disclaimer

The Searle Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore The Searle Company‘s full profile, request access.

Request a free trial

The Searle Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

The Searle Company Acquisitions (1)

The Searle Company’s most recent deal was a Merger/Acquisition with Searle Pakistan. The deal was made on 25-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Searle Pakistan 25-Aug-2020 Merger/Acquisition Pharmaceuticals
To view The Searle Company’s complete acquisitions history, request access »

The Searle Company ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

43.19 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view The Searle Company’s complete esg history, request access »

The Searle Company FAQs

  • When was The Searle Company founded?

    The Searle Company was founded in 1965.

  • Where is The Searle Company headquartered?

    The Searle Company is headquartered in Karachi, Pakistan.

  • What is the size of The Searle Company?

    The Searle Company has 3,285 total employees.

  • What industry is The Searle Company in?

    The Searle Company’s primary industry is Pharmaceuticals.

  • Is The Searle Company a private or public company?

    The Searle Company is a Public company.

  • What is The Searle Company’s stock symbol?

    The ticker symbol for The Searle Company is SEARL.

  • What is the current stock price of The Searle Company?

    As of 12-Nov-2026 the stock price of The Searle Company is $0.28.

  • What is the current market cap of The Searle Company?

    The current market capitalization of The Searle Company is $163M.

  • What is The Searle Company’s current revenue?

    The trailing twelve month revenue for The Searle Company is $136M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process